Bio-Pharmaceutical Stocks Climb 51% for First-Half of 2000.Business Editors/Health and Medical Writers PRINCETON, N.J.--(BW HealthWire)--July 24, 2000 BioGene Capital Markets, ( http://www.biogenecapital.com ) an investment banking firm specializing in biotechnology, genomics, gene therapy, and developing pharmaceuticals released today its analysis of share price performance for more than 400 public bio-pharmaceutical companies through the first half of 2000. The Bio-Pharmaceutical Group posted a 53.1 percent increase from share prices ended 12/31/99, and surpassing the first-quarter 2000 Group gain of 31.1 percent. For calendar year 1999, Group share prices rose 37.4 percent, compared to an 11.4 percent increase for calendar year 1998 and an 11.5 percent increase for 1997. In 1996, share prices for the Bio-Pharmaceutical Group increased 7.0 percent, and in 1995, increased 52.3 percent. For the entire Healthcare Industry, representing more than 1,000 public companies, Healthcare industry share prices increased 28 percent for the first-half of 2000, compared to share prices ended 12/31/99. The Biotechnology Segment (under $10 million in sales) led segment growth for the first six months, rising 82.9 percent. Other leading segments were: Diagnostics, up 68.3%, Genetics, up 62.5%, Drug Distribution, up 59.4%, Pharmaceuticals, up over 50%, Drug Delivery, up 47.9%, Generics, up 45%, and Biotechnology (under $10 million in sales), up 41.6 percent. A representative list of companies reviewed in the report include: (by stock symbol), ABT, ALKS, AMGN, DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. , BGEN, CHIR, GENZ, GILD, MEDI, MEDX, PDLI, TRMS, CTIC, CVTX, IMCL, MEDX, INHL, MYL, KG, WPI, CALP, CYTC, DP, CLTX, HGSI, VICL, CRA See Community Reinvestment Act. , AVGN, INCY, BRL BRL In currencies, this is the abbreviation for the Brazilian Real. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. , ADRX, CRGN, MLMN, HYSQ, MYGN, ORCH, AGN, AZN, GLX, MRK, BMY, AVE, PFE, PHA PHA abbr. phytohemagglutinin PHA phytohemagglutinin, a plant lectin. , ABSC, AVIR, CRXA, ENZN, LLY, SGP, AZA, ELN, ALXN, SEPR, TTP TTP (thymidine triphosphate): see thymine. , CVD CVD Cardiovascular disease, see there , QTRN, BVF, TECH, CAH CAH congenital adrenal hyperplasia. CAH Congenital adrenal hyperplasia, see there , ALO. The full report, including graphs and tables showing all 10 segments can be reviewed at BioGene Capital Markets website: http://www.biogenecapital.com. BioGene Capital Markets is a boutique financial advisory and investment banking firm specializing in biotechnology, genomics, gene therapy, developing pharmaceuticals and related fields. The firm provides transactional, financial and strategic advisory services to clients having an interest in corporate or technology acquisitions, financing, mergers and acquisitions, licensing and distribution. BioGene Capital Markets is a strategic alliance led by Century Capital Associates of Princeton, New Jersey
Princeton, New Jersey is located in Mercer County, New Jersey, United States. Princeton University has been sited in the town since 1756. ( http://www.century-capital.com ) and HealthCare Markets Group, Inc. ( http://www.hcmarkets.com ). |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion